Literature DB >> 1595588

Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations.

J W Miller1, J D Ribaya-Mercado, R M Russell, D C Shepard, F D Morrow, E F Cochary, J A Sadowski, S N Gershoff, J Selhub.   

Abstract

The catabolism of homocysteine through cystathionine synthesis requires pyridoxal-5'-phosphate, thus the effect of vitamin B-6 deficiency on plasma homocysteine concentrations was evaluated. Total fasting plasma homocysteine concentrations were measured in 11 elderly subjects aged 64.4 +/- 1.7 y (mean +/- SE) who consumed a vitamin B-6-deficient diet for less than or equal to 20 d. Only 1 of the 11 subjects was found to have elevated homocysteine concentrations even though all subjects exhibited high urinary xanthurenic acid concentrations after a tryptophan load, a measure indicative of vitamin B-6 deficiency. In a supporting study, fasting plasma homocysteine concentrations were measured in 3- and 23-mo-old rats fed vitamin B-6-deficient diets and were compared with those of vitamin B-6-replete, pair-fed controls. There was no difference in homocysteine concentrations between deficient and pair-fed animals after 6 wk of the dietary regimen for either age group; after 9 wk a modest elevation was observed in the 3-mo-old deficient rats whereas no difference was observed for the 23-mo-old rats. It is concluded that fasting plasma homocysteine concentrations are not initially elevated in vitamin B-6 deficiency and therefore fasting plasma homocysteine concentrations are not a good indicator of vitamin B-6 status.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595588     DOI: 10.1093/ajcn/55.6.1154

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  19 in total

1.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism.

Authors:  J B Ubbink; A van der Merwe; R Delport; R H Allen; S P Stabler; R Riezler; W J Vermaak
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

Authors:  A B Guttormsen; P M Ueland; I Nesthus; O Nygård; J Schneede; S E Vollset; H Refsum
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.

Authors:  M A Mansoor
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

4.  Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.

Authors:  Valentina Medici; Janet M Peerson; Sally P Stabler; Samuel W French; Jesse F Gregory; Maria Catrina Virata; Antony Albanese; Christopher L Bowlus; Sridevi Devaraj; Edward A Panacek; Nazir Rahim; John R Richards; Lorenzo Rossaro; Charles H Halsted
Journal:  J Hepatol       Date:  2010-05-31       Impact factor: 25.083

5.  Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women.

Authors:  Yvonne Lamers; Bonnie Coats; Maria Ralat; Eoin P Quinlivan; Peter W Stacpoole; Jesse F Gregory
Journal:  J Nutr       Date:  2011-03-23       Impact factor: 4.798

6.  The atherogenic effect of excess methionine intake.

Authors:  Aron M Troen; Esther Lutgens; Donald E Smith; Irwin H Rosenberg; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  B-vitamin status and bone mineral density and risk of lumbar osteoporosis in older females in the United States.

Authors:  Regan L Bailey; Anne C Looker; Zhaohui Lu; Ruzong Fan; Heather A Eicher-Miller; Tala H Fakhouri; Jaime J Gahche; Connie M Weaver; James L Mills
Journal:  Am J Clin Nutr       Date:  2015-07-29       Impact factor: 7.045

8.  Serum levels of homocysteine in mice with malignant tumours.

Authors:  Mabood Qureshi; Xueshu Zhang; Inam Ul-Haq; Jim Xiang; Kailash Prasad
Journal:  Exp Clin Cardiol       Date:  2003

9.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

Authors:  L A Kluijtmans; L P van den Heuvel; G H Boers; P Frosst; E M Stevens; B A van Oost; M den Heijer; F J Trijbels; R Rozen; H J Blom
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

Review 10.  Biomarkers of Nutrition for Development-Folate Review.

Authors:  Lynn B Bailey; Patrick J Stover; Helene McNulty; Michael F Fenech; Jesse F Gregory; James L Mills; Christine M Pfeiffer; Zia Fazili; Mindy Zhang; Per M Ueland; Anne M Molloy; Marie A Caudill; Barry Shane; Robert J Berry; Regan L Bailey; Dorothy B Hausman; Ramkripa Raghavan; Daniel J Raiten
Journal:  J Nutr       Date:  2015-06-03       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.